Navigation Links
Renaissance in new drugs for rare diseases: Report in world's largest scientific socity magazine
Date:5/13/2013

ther driving force. They are directly funding some research, and they're working smarter and getting creative about drawing attention and dollars for research. Deeper insights into the genetics of these disorders and federal legislation extending patent protection for these medicines also have helped.

Jarvis spent time with several families of children dealing with rare diseases, saw their passion first-hand and includes their stories in the article.

It describes how venture capital firms have become engaged in funding research on rare diseases to the point where more venture capital money may be going toward drugs for rare diseases than for any other type of medication, except for cancer drugs.

Most of the 7,000 rare diseases result from genetic defects, and about half of those affect children. In some cases, children die before they reach adulthood without treatment. Many of the rarest of these diseases affect only a few dozen to a few thousand people. Hunter syndrome, for instance, affects fewer than 500 boys in the U.S., and Gaucher's disease affects about 5,000 people.

Misdiagnosis is a common theme, Jarvis writes. It takes the typical patient 7.6 years and consultations with eight physicians to finally discover what's really going on.

Jarvis reports that until recently, pharmaceutical companies often focused on "blockbuster" drugs, medicines for common conditions like high cholesterol, high blood pressure and diabetes that would have annual sales of at least $1 billion. However, companies like Genzyme, a subsidiary of Sanofi, showed that medications for rare diseases can make money by pricing them high enough to cover research and development costs, and having insurance companies reimburse most patient costs. That's an attractive scenario for larger companies, which are getting into the market, even creating special units focused on this segment, Jarvis adds.

Scientists know more about rare diseases tha
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
2. Nanopills release drugs directly from the inside of cells
3. Genetic variation in East Asians found to explain resistance to cancer drugs
4. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
5. Internet and new drugs: A challenge for public health
6. Study raises questions about use of anti-epilepsy drugs in newborns
7. Drugs from lizard saliva reduces the cravings for food
8. A new method detects traces of veterinary drugs in baby food
9. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
10. MIT-designed cooler preserves tuberculosis drugs, records doses
11. Arsenic for better drugs and cleaner crops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... one of the commonest and most serious infections occurring ... cohort and case control studies published in BioMed Central,s ... current smokers with HIV were at double the risk ... people stopped smoking their risk was reduced. The ...
... using any drugs? Starve it to death by ... HDL cholesterol. Northwestern Medicine researchers discovered this ... agent. It appears to the cancerous lymphoma cell like a ... the cell, it actually plugs it up and blocks cholesterol ...
... survivors with plenty of tricks for staying alive. Researchers have ... tumor suppressor BRCA1 can resume one form of DNA repair, ... the January 21 st issue of The ... protein helps to mend double-strand DNA breaks by promoting homologous ...
Cached Biology News:New way to kill lymphoma without chemotherapy 2New way to kill lymphoma without chemotherapy 3Enzyme helps cancer cells avoid genetic instability 2Enzyme helps cancer cells avoid genetic instability 3
(Date:1/22/2015)... The laboratory information management systems market ... number of technological advancements due to factors such as ... to integrate healthcare systems, and increasing government support for ... integration. Key players in the market focus on technological ...
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics ... from a new partner. STT-Systems has developed an ... years, with offerings in the optical-motion capture, 3D scanning, and ... measurement unit), iSen, is opening eyes around the world. With ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Diagenode, ... such as the Bioruptor® and complete solutions for ... for chromatin immunoprecipitation, alleviating the need for manual ... controls needed for ChIP of histones or transcription ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2
... Haven, Conn. A study by Yale researchers offers a ... individuals suggesting that it is due less to single ... cause extended segments of the human genome to be missing, ... for identifying genetic differences has traditionally been on point mutations ...
... enzymes from E. coli bacteria, Duke University chemists and ... of features imprinted to create microdevices such as labs-on-a-chip. ... measuring close to 1 nanometer, or billionths of a ... 2007 issue of the Journal of Organic Chemistry. ...
... Coherent, Inc.,(Nasdaq: COHR ) today announced that ... financial statements to correct errors related to,accounting for ... Special Committee was established by,Coherent,s Board of Directors ... historical stock option practices. The Company,requested the independent ...
Cached Biology Technology:Individual differences caused by shuffled chunks of DNA in the human genome 2Individual differences caused by shuffled chunks of DNA in the human genome 3Using catalysts to stamp nanopatterns without ink 2Using catalysts to stamp nanopatterns without ink 3Coherent Announces Restatement Related to Stock-Based Compensation 2Coherent Announces Restatement Related to Stock-Based Compensation 3Coherent Announces Restatement Related to Stock-Based Compensation 4
... the computing power of your ValveBank system! ... sequences with a Macintosh computer using graphic ... to disk, print out program listings, then ... in one simple step., EasyCode is used ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
... is a dedicated fluorometer with ... kinds of assays in industrial ... clinical applications. Cell biology, immunology ... important application areas. Robot-friendly hardware ...
Biology Products: